跳至主要内容
临床试验/KCT0006452
KCT0006452招募中未知

Shared Decision Making for choosing renAl Replacement Therapy in chronic kidney disease patients

Seoul National University Bundang Hospital0 个研究点目标入组 1,194 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 80?(Year)(—)
性别
All

入选标准

  • Chronic kidney disease grade 5 (defined as estimated glomerular filtration rate < 15 ml/dL/1.73m2 at least 2 times at intervals of 2 weeks or longer)
  • Age between 19 and 80 years
  • The nephrologists anticipate treating the patient with kidney replacement therapy within 12 months
  • Written informed consent

排除标准

  • Contraindication to perform peritoneal dialysis due to abdominal surgery
  • Life expectancy is less than 6 months due to underlying diseases
  • Patients who have enrolled in other clinical trials within 3 months or plan to participate in other clinical trials during this clinical trial period
  • Patients judged by the investigator to be inappropriate for participation in this clinical trial.

研究者

相似试验